MedTrace Logo

Effects of Dexamethasone on Common Bile Duct Cannulation Time

NCT05945797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-03-21

No results posted yet for this study

Summary

The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP.

Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.

Conditions

  • Common Bile Duct Diseases
  • Common Bile Duct Calculi
  • Common Bile Duct Stricture
  • Common Bile Duct Neoplasms
  • Common Bile Duct Dilatation

Interventions

DRUG

Dexamethasone 4mg

An injection of 4mg of dexamethasone will be given to patients approximately 2 to 4 hours prior to the procedure of ERCP.

Sponsors & Collaborators

  • Gujranwala medical college District Headquarters Hospital, Gujranwala

    lead OTHER

Principal Investigators

  • Najam us Sehar Saeed, FCPS-Gastro · GMC-DHQ Hospital, Gujwanala, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-04-12
Completion
2024-05-16

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05945797 on ClinicalTrials.gov